ArticleFrontiers in oncology2018

Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status.

Hind Hafsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.